News

FDA chief confirms mifepristone review but “no plans” to change access

FDA Commissioner Dr. Marty Makary joins Morning Joe to address the agency’s controversial decision to keep Juul e-cigarettes ...

Makary ally named to key FDA drug post

Dr. George Tidmarsh, a Stanford pediatrics adjunct professor and former pharmaceutical executive, is FDA Commissioner Marty Makary’s pick to be the nation’s top drug regulator.

FDA Commissioner: 100 Days of Change—Modernizing the FDA for a Healthier America | Opinion

The Food and Drug Administration (FDA) can maintain its high bar for safety and efficacy, and also cut the waste and ...
STAT1d

New head of FDA drug center is a biotech veteran and an outspoken critic of the academic establishment

“Dr. Tidmarsh is an accomplished physician-scientist and leader whose experience spans the full arc of drug development — ...
Fierce Pharma1d

FDA names next CDER director in biotech vet George Tidmarsh

FDA Commissioner Marty Makary, M.D., has made his pick for the next director of the FDA’s Center for Drug Evaluation and ...
Everyday Health on MSN1h

New FDA Panel Recommends Removing Warnings From Estrogen Therapies for Menopause

The panelists said that vaginal creams and other localized therapies for menopause are safe and vastly underused by women who could benefit.
STAT8dOpinion

The FDA commissioner is a gifted talker — but the job is about more than that

FDA Commissioner Marty Makary's vision for the agency risks the best of an agency that mostly has functioned well for the ...

FDA Is Looking for Expanded Power to Crack Down on Illegal Vapes

The Food and Drug Administration is taking a closer look at kratom extracts and preparing to ask Congress for expanded ...